Utah Medical Products (NASDAQ:UTMD) versus Inovio Pharmaceuticals (NASDAQ:INO) Head to Head Review

Utah Medical Products (NASDAQ:UTMD) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.

Institutional and Insider Ownership

73.8% of Utah Medical Products shares are owned by institutional investors. Comparatively, 47.3% of Inovio Pharmaceuticals shares are owned by institutional investors. 7.3% of Utah Medical Products shares are owned by insiders. Comparatively, 7.9% of Inovio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.



Analyst Recommendations

This is a breakdown of current recommendations and price targets for Utah Medical Products and Inovio Pharmaceuticals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Utah Medical Products 0 0 0 0 N/A
Inovio Pharmaceuticals 0 0 5 0 3.00

Inovio Pharmaceuticals has a consensus price target of $8.52, suggesting a potential upside of 216.88%. Given Inovio Pharmaceuticals’ higher possible upside, analysts clearly believe Inovio Pharmaceuticals is more favorable than Utah Medical Products.

Profitability

This table compares Utah Medical Products and Inovio Pharmaceuticals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Utah Medical Products 42.07% 16.47% 14.51%
Inovio Pharmaceuticals -295.24% -97.95% -61.34%

Volatility & Risk

Utah Medical Products has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 2.03, meaning that its share price is 103% more volatile than the S&P 500.

Dividends

Utah Medical Products pays an annual dividend of $1.10 per share and has a dividend yield of 1.3%. Inovio Pharmaceuticals does not pay a dividend. Utah Medical Products has increased its dividend for 8 consecutive years.

Earnings & Valuation

This table compares Utah Medical Products and Inovio Pharmaceuticals’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Utah Medical Products $42.00 million 7.74 $18.56 million N/A N/A
Inovio Pharmaceuticals $30.48 million 8.65 -$96.97 million ($1.05) -2.56

Utah Medical Products has higher revenue and earnings than Inovio Pharmaceuticals.

Summary

Utah Medical Products beats Inovio Pharmaceuticals on 9 of the 14 factors compared between the two stocks.

About Utah Medical Products

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.

About Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical studies of its proprietary SynCon immunotherapies for human papillomavirus-caused pre-cancers and cancers; bladder cancer; glioblastoma multiforme; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include MedImmune, Limited; The Wistar Institute; University of Pennsylvania; GeneOne Life Science Inc.; ApolloBio Corporation; Regeneron Pharmaceuticals, Inc.; Genentech, Inc.; Plumbline Life Sciences, Inc.; Drexel University; National Institute of Allergy and Infectious Diseases; United States Military HIV Research Program; U.S. Army Medical Research Institute of Infectious Diseases; National Institutes of Health; HIV Vaccines Trial Network; Defense Advanced Research Projects Agency; the Parker Institute for Cancer Immunotherapy; and Coalition for Epidemic Preparedness Innovations. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.